RPHMReneo Pharmaceuticals, Inc.

Nasdaq reneopharma.com


$ 1.74 $ 0.01 (0.58 %)    

Friday, 03-May-2024 15:59:55 EDT
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 1.74
$ 1.73
$ 0.00 x 0
$ 0.00 x 0
$ 1.73 - $ 1.77
$ 0.98 - $ 9.93
110,683
na
53.38M
$ 0.92
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-28-2024 12-31-2023 10-K
2 11-13-2023 09-30-2023 10-Q
3 08-10-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 03-27-2023 12-31-2022 10-K
6 11-08-2022 09-30-2022 10-Q
7 08-09-2022 06-30-2022 10-Q
8 05-10-2022 03-31-2022 10-Q
9 03-23-2022 12-31-2021 10-K
10 11-12-2021 09-30-2021 10-Q
11 08-11-2021 06-30-2021 10-Q
12 05-20-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 reneo-pharmaceuticals-q4-gaap-eps-070-misses-062-estimate-cash-cash-equivalents-and-short-term-investments-of-103m

Reneo Pharmaceuticals (NASDAQ:RPHM) reported quarterly losses of $(0.70) per share which missed the analyst consensus estimate ...

 why-reneo-pharmaceuticals-shares-are-trading-higher-by-around-14-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an ac...

 why-ascent-industries-shares-are-trading-higher-by-7-here-are-20-stocks-moving-premarket

Shares of Ascent Industries Co. (NASDAQ: ACNT) rose sharply in pre-market trading as the company reported the sale of the busi...

 reneo-pharmaceuticals-inc-says-on-dec-26-concentra-an-affiliate-of-tang-capital-partners-sent-acquisition-proposal-to-the-co-on-behalf-of-concentra-biosciences-submit-non-binding-proposal-to-acquire-100-of-equity-of-reneo-for-180-per-share

Concentra Biosciences, LLC4747 Executive Drive, Suite 210 | San Diego, CA 92121December 26, 2023Board of DirectorsReneo Pharmac...

 hc-wainwright--co-downgrades-reneo-pharmaceuticals-to-neutral-lowers-price-target-to-15

HC Wainwright & Co. analyst Mitchell Kapoor downgrades Reneo Pharmaceuticals (NASDAQ:RPHM) from Buy to Neutral and lower...

 jefferies-downgrades-reneo-pharmaceuticals-to-hold-lowers-price-target-to-18

Jefferies analyst Eun Yang downgrades Reneo Pharmaceuticals (NASDAQ:RPHM) from Buy to Hold and lowers the price target from ...

 leerink-partners-downgrades-reneo-pharmaceuticals-to-market-perform-announces-1-price-target

Leerink Partners analyst Joseph Schwartz downgrades Reneo Pharmaceuticals (NASDAQ:RPHM) from Outperform to Market Perform an...

 nasdaq-turns-lower-us-retail-sales-top-estimates

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning lower on Thursday. The Dow traded up 0.0...

 why-amtech-systems-shares-are-trading-higher-by-over-30-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Amtech Systems, Inc. (NASDAQ: ASYS) shares fell sharply during Thursday’s session after the company reported worse-t...

 crude-oil-rises-sharply-adobe-shares-fall

U.S. stocks traded higher midway through trading, following the release of economic reports on Thursday. The Dow traded up 0.4...

 why-is-genetic-disease-focused-reneo-pharmaceuticals-stock-plummeting-today

Reneo Pharmaceuticals Inc (NASDAQ: RPHM) shares are sinking after the company released data from its pivotal STRIDE Phase 2b st...

 reneo-pharmaceuticals-announced-its-pivotal-stride-study-of-mavodelpar-in-adult-patients-with-primary-mitochondrial-myopathies-did-not-meet-its-primary-efficacy-or-secondary-efficacy-endpoint

The STRIDE study did not meet its primary or secondary efficacy endpoint The company to suspend mavodelpar development and impl...

 william-blair-initiates-coverage-on-reneo-pharmaceuticals-with-outperform-rating

William Blair analyst Myles Minter initiates coverage on Reneo Pharmaceuticals (NASDAQ:RPHM) with a Outperform rating.

 hc-wainwright--co-reiterates-buy-on-reneo-pharmaceuticals-maintains-30-price-target

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Reneo Pharmaceuticals (NASDAQ:RPHM) with a Buy and maintains $30 ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION